The use of other protease inhibitors specific for cathepsins, elastase, and other types of proteases previously found in SF of RA patients [29,35] will be necessary to determine the contribution of these proteases to the NPA in various diseases. The gene discussed is CTSS; the disease is rheumatoid arthritis.